The therapeutic efficacy of cancer therapeutics is frequently limited by poor tumour selectivity, systemic toxicity, and the emergence of drug resistance, underscoring the need for advanced nanoscale drug delivery systems...
Tiwari et al. (Thu,) studied this question.